Drawing for EVICORE ONCONNECT

USPTO serial 88255839

EVICORE ONCONNECT

Reviewed by CopyMark Law Group

Reg. 6211778Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
RANNS, NATHAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVICORE ONCONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Cost management for the health care benefit plans of others; Drug utilization review services; pharmaceutical cost management services; medical cost management; managed care services, namely, utilization review and pre-certification services; evidence-based health care cost management services and healthcare utilization and review services; Patient care management services, namely, pharmaceutical cost management; medical and pharmaceutical cost management services in the fields of medical oncology, radiation therapy, genetic laboratory services, diagnostic radiology, inpatient admissions, cancer surgery, and healthcare services in the field of oncologyACTIVE
036Pharmacy benefit management services; medical benefit management services; medical and pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plansACTIVE
042Software as a service (SaaS) services featuring software for use with evidence-based healthcare and insurance, namely, medical utilization review and reporting and verifying the requesting provider's adherence to evidence-based medical and pharmacy guidelines; software as a service (SaaS) services featuring software for optimizing healthcare utilization, managing utilization and financial risk for healthcare payers, assisting physicians in making clinical decisions, and analyzing data to help health care providers track clinical decisions and develop best practices; providing online non-downloadable software for use in managing the quality and cost of healthcare; providing online non-downloadable software for use in obtaining prior authorizations for care to aid in schedule services and delivering care to patients; software as a service (SaaS) services featuring software for the use with managing medical and pharmacy benefits in the fields of medical oncology, radiation therapy, genetic laboratory services, diagnostic radiology, inpatient admissions, cancer surgery, and healthcare services in the field of oncology; organization and coordination of health care services, namely, genetic laboratory servicesACTIVE
044advisory services and consultancy regarding healthcare; healthcare services, namely, disease management programs; organization and coordination of health care services, namely, medical oncology services, radiation therapy, diagnostic radiology services, hospital admissions, and surgeryACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 19, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 27, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 24, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 3, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2020EX2GSOU EXTENSION 2 GRANTED
Oct 2, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 1, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE
Sep 25, 2020IUAFUSE AMENDMENT FILED
Sep 25, 2020EXT2SOU EXTENSION 2 FILED
Sep 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 25, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 26, 2020EX1GSOU EXTENSION 1 GRANTED
Mar 26, 2020EXT1SOU EXTENSION 1 FILED
Mar 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2019ALIEASSIGNED TO LIE
Jun 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2019XAECEXAMINER'S AMENDMENT ENTERED
Jun 20, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 20, 2019GNEAEXAMINERS AMENDMENT E-MAILED
Jun 20, 2019CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 17, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2019DOCKASSIGNED TO EXAMINER
Jan 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance